These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12798954)

  • 61. Effects of azimilide on cardiovascular tissues from normo- and hypertensive rats.
    Nand V; Doggrell SA
    J Cardiovasc Pharmacol; 2000 Aug; 36(2):209-17. PubMed ID: 10942163
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Self-augmentation of the lengthening of repolarization is related to the shape of the cardiac action potential: implications for reverse rate dependency.
    Virág L; Acsai K; Hála O; Zaza A; Bitay M; Bogáts G; Papp JG; Varró A
    Br J Pharmacol; 2009 Apr; 156(7):1076-84. PubMed ID: 19226285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide.
    Phillips L; Grasela TH; Agnew JR; Ludwig EA; Thompson GA
    Clin Pharmacol Ther; 2001 Oct; 70(4):370-83. PubMed ID: 11673753
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bepridil differentially inhibits two delayed rectifier K(+) currents, I(Kr) and I(Ks), in guinea-pig ventricular myocytes.
    Wang JC; Kiyosue T; Kiriyama K; Arita M
    Br J Pharmacol; 1999 Dec; 128(8):1733-8. PubMed ID: 10588929
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart.
    Chang GJ; Su MJ; Hung LM; Lee SS
    Br J Pharmacol; 2002 Jun; 136(3):459-71. PubMed ID: 12023949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Azimilide dihydrochloride, a novel antiarrhythmic agent.
    Karam R; Marcello S; Brooks RR; Corey AE; Moore A
    Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve.
    Biliczki P; Virág L; Iost N; Papp JG; Varró A
    Br J Pharmacol; 2002 Oct; 137(3):361-8. PubMed ID: 12237256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of the in vivo and in vitro electrophysiological effects of the novel antiarrhythmic agent AZD7009 in atrial and ventricular tissue of the dog.
    Carlsson L; Chartier D; Nattel S
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):123-32. PubMed ID: 16424796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of I(Ca,L).
    Christ T; Wettwer E; Ravens U
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):393-400. PubMed ID: 15959721
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential Electrophysiologic Effects of Chronically Administered Amiodarone on Canine Purkinje Fibers versus Ventricular Muscle.
    Papp JG; Németh M; Krassói I; Mester L; Hála O; Varró A
    J Cardiovasc Pharmacol Ther; 1996 Oct; 1(4):287-296. PubMed ID: 10684429
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
    Amos GJ; Abrahamsson C; Duker G; Hondeghem L; Palmer M; Carlsson L
    Cardiovasc Res; 2001 Feb; 49(2):351-60. PubMed ID: 11164845
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Azimilide dihydrochloride: a new class III anti-arrhythmic agent.
    Abrol R; Page RL
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2705-15. PubMed ID: 11060832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of intravenous azimilide on cardiac performance, fibrillation threshold, and hemodynamics in anesthetized dogs.
    Brooks RR; Finch SL
    Arzneimittelforschung; 2000 Jul; 50(7):597-605. PubMed ID: 10965415
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relation between vascular relaxant and cardiac electrophysiological effects of pinacidil.
    Steinberg MI; Ertel P; Smallwood JK; Wyss V; Zimmerman K
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S30-40. PubMed ID: 2466177
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of K+ channel blockers on the action potential of hypoxic rabbit myocardium.
    Ruiz Petrich E; Leblanc N; deLorenzi F; Allard Y; Schanne OF
    Br J Pharmacol; 1992 Aug; 106(4):924-30. PubMed ID: 1393290
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of polydatin on action potential in ventricular papillary muscle of rat and the underlying ionic mechanism.
    Zhang LP; Wei Y; Song SL; Cheng M; Zhang Y
    Sheng Li Xue Bao; 2011 Feb; 63(1):48-54. PubMed ID: 21340434
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles.
    Pérez O; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1997 Jan; 120(2):187-92. PubMed ID: 9117108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.